Methodology and application of adaptive and sequential approaches in contemporary clinical trials

DOI10.1155/2012/527351zbMath1282.62230OpenAlexW2006128945WikidataQ58910970 ScholiaQ58910970MaRDI QIDQ1929694

Jeanne Kowalski, Ye Cui, Zhengjia Chen, Yichuan Zhao

Publication date: 9 January 2013

Published in: Journal of Probability and Statistics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1155/2012/527351

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Robustness and adaptive procedures (parametric inference) (62F35) Sequential statistical design (62L05)

Uses Software

• BayesDA

Cites Work

• Unnamed Item
• Unnamed Item
• Unnamed Item
• Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
• Dose finding with escalation with overdose control (EWOC) in cancer clinical trials
• A review of phase 2-3 clinical trial designs
• Optimal Bayesian-feasible dose escalation for cancer phase I trials
• Seamlessly Expanding a Randomized Phase II Trial to Phase III
• Design and Analysis of Phase I Clinical Trials
• Designs for Group Sequential Phase II Clinical Trials
• One-Sided Sequential Stopping Boundaries for Clinical Trials: A Decision- Theoretic Approach
• One-Sample Multiple Testing Procedure for Phase II Clinical Trials
• An improved method for deriving optimal one-sided group sequential tests
• Designed Extension of Studies Based on Conditional Power
• Optimal asymmetric one-sided group sequential tests
• Modification of Sample Size in Group Sequential Clinical Trials
• A Sample-Size-Optimal Bayesian Procedure for Sequential Pharmaceutical Trials
• Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials

This page was built for publication: Methodology and application of adaptive and sequential approaches in contemporary clinical trials